drugset / Trial / NCT01021007

Clinical Research Study Efficacy of a Prototype Oral Rinse

NCT01021007 ↗

Phase 3 Completed 67 enrolled Colgate Palmolive
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the efficacy of an oral rinse on dental plaque and gingival inflammation

Timeline

Start
2007-10
Primary completion
2007-11
Completion
2007-11

Outcome

Mixed primary results

registry MEAN Negative Control Rinse: 1.90 (Standard Deviation 0.19) Units on a scale NCT01021007 ↗

registry MEAN Iocide Mouthrinse: 1.84 (Standard Deviation 0.23) Units on a scale NCT01021007 ↗

registry analysis (superiority or other test); Negative Control Rinse vs Iocide Mouthrinse; p = 0.005; ANCOVA NCT01021007 ↗

registry MEAN Negative Control Rinse: 40.82 (Standard Deviation 16.93) bleeding sites NCT01021007 ↗

registry MEAN Iocide Mouthrinse: 34.91 (Standard Deviation 23.83) bleeding sites NCT01021007 ↗

registry analysis (superiority or other test); Negative Control Rinse vs Iocide Mouthrinse; p = 0.05; ANCOVA NCT01021007 ↗

registry MEAN Negative Control Rinse: 2.47 (Standard Deviation 0.61) Units on a scale NCT01021007 ↗

registry MEAN Iocide Mouthrinse: 2.11 (Standard Deviation 0.70) Units on a scale NCT01021007 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Iodine Other / unclassified — —